Estimates Revisions Tyra Biosciences, Inc.
Stocks
TYRA
US90240B1061
Biotechnology & Medical Research
|
Real-time Estimate
Cboe BZX
10:07:10 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 25.56 USD | -2.16% |
|
-1.36% | -2.26% |
| 08-11 | BofA Adjusts Price Target on Tyra Bioscience to $39 From $42 | MT |
| 08-04 | Tyra Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- TYRA Stock
- Consensus Tyra Biosciences, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
